1,185 reports of this reaction
3.2% of all VALPROATE SODIUM reports
#2 most reported adverse reaction
DRUG INTERACTION is the #2 most commonly reported adverse reaction for VALPROATE SODIUM, manufactured by Fresenius Kabi USA, LLC. There are 1,185 FDA adverse event reports linking VALPROATE SODIUM to DRUG INTERACTION. This represents approximately 3.2% of all 37,274 adverse event reports for this drug.
Patients taking VALPROATE SODIUM who experience drug interaction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INTERACTION is moderately reported among VALPROATE SODIUM users, representing a notable but not dominant share of adverse events.
In addition to drug interaction, the following adverse reactions have been reported for VALPROATE SODIUM:
The following drugs have also been linked to drug interaction in FDA adverse event reports:
DRUG INTERACTION has been reported as an adverse event in 1,185 FDA reports for VALPROATE SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INTERACTION accounts for approximately 3.2% of all adverse event reports for VALPROATE SODIUM, making it one of the most commonly reported side effect.
If you experience drug interaction while taking VALPROATE SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.